Defending Departing Employees and Competitors Against Trade Secret Injunctions: Narrowing Relief and Defeating Irreparable Harm

Barbara A. Fiacco
Robert Haney, Jr.
Allison Anderson
Urszula Nowak
Barbara A. Fiacco | Foley Hoag LLP
Robert Haney, Jr. | Foley Hoag LLP
Allison Anderson | Foley Hoag LLP
Urszula Nowak | Foley Hoag LLP

Live Video-Broadcast: December 16, 2026

2 hour CLE

Tuition: $195.00
Subscribe to Federal Bar Association CLE Pass...
Co-Sponsored by myLawCLE
Get this course, plus over 1,000+ of live webinars.
Learn More
Training 5 or more people?

Sign-up for a law firm subscription plan and each attorney in the firm receives free access to all CLE Programs

Program Summary

 

What to Concede, What to Contest: The Defense Side of a Trade Secret Injunction

Recent decisions, including the Massachusetts decision in Daikin Applied Americas Inc. v. Russo, highlight a recurring question in trade secret litigation: when a plaintiff seeks a temporary restraining order or preliminary injunction, what relief should the defense concede, what should it contest, and how can it contest preliminary relief most effectively? This program examines practical defense strategies for responding to these motions, building the record, and arguing against injunctive relief.

Venue and choice of law can be challenged. Non-competes interact with the trade secret issues. Strategic concessions and stipulated orders shape what remains in dispute. Hiring companies must weigh separate counsel for the employees. The evidentiary record on harm and damages, and how it is presented across jurisdictions, drives the irreparable harm argument.

Attendees leave with a defense-side approach to both stages: an early response strategy for TRO and preliminary injunction motions, and a plan for briefing and arguing the opposition. That plan covers arguing public policy concerns, narrowing the scope of requested relief, requesting a bond, and preparing hearing strategy and proposed orders. These are practitioner judgment calls, taught by litigators who make them.

Key topics to be discussed:

  • Early Response Strategy
    How to shape the first response to a TRO or preliminary injunction motion, including when to challenge venue and choice of law.
  • Non-Competes and Hiring Companies
    How non-competes interact with the trade secret issues, and what hiring companies must consider, including separate counsel for the employees.
  • Concessions and Stipulated Orders
    How to decide what relief to concede and what to contest, and how to use strategic concessions and stipulated orders.
  • Harm and Damages Record
    How to build the evidentiary record on harm and damages and present that evidence across jurisdictions.
  • Irreparable Harm and Public Policy
    How to brief and argue lack of irreparable harm as a ground for opposition and effectively argue public policy concerns.
  • Narrowing Relief and Bond
    How to narrow the scope of requested relief, request a bond, and prepare hearing strategy and proposed orders.

This course is co-sponsored with myLawCLE.

Date / Time: December 16, 2026

  • 12:00 pm – 2:10 pm Eastern
  • 11:00 am – 1:10 pm Central
  • 10:00 am – 12:10 pm Mountain
  • 9:00 am – 11:10 am Pacific

Closed-captioning available

Speakers

Barbara A. Fiacco, Partner | Foley Hoag LLP

Barbara A. Fiacco co-chairs the Patent & Trade Secrets Litigation Practice and the Intellectual Property Department at Foley Hoag LLP in Boston. She represents life sciences companies and research institutions in trade secret, inventorship, and collaboration disputes, alongside patent infringement and other commercial litigation.

  • Education & Credentials

Ms. Fiacco earned her J.D., cum laude, from Harvard Law School in 1996 and her A.B., magna cum laude, with high honors in government, from Dartmouth College in 1991. She clerked for Judge Richard J. Cardamone of the U.S. Court of Appeals for the Second Circuit. She is admitted in Massachusetts and before the U.S. District Court for the District of Massachusetts, the U.S. Courts of Appeals for the First and Federal Circuits, and the U.S. Supreme Court.

  • Recognition & Leadership

Best Lawyers has listed Ms. Fiacco for Trade Secrets Law (2025-2027) and named her Boston Trade Secrets Law Lawyer of the Year (2026). WIPR lists her as Recommended in USA Trade Secrets (2025-2026). Chambers USA has named her a leading Intellectual Property lawyer in Massachusetts (2011, 2018-2026), and Lawdragon has included her among the 500 Leading Litigators in America (2022-2026). She served as President of the American Intellectual Property Law Association (AIPLA) from 2019 to 2020 and is a Past President of the United States section of the International Association for the Protection of Intellectual Property (AIPPI-US).

  • Professional Involvement

Her recent speaking engagements include WIPR Trade Secrets East (October 2026), Trade Secret Legal Protection North America (September 2026), and Trade Secret Boston 2025, along with a May 2023 program on preliminary injunctions in federal court in IP cases. In November 2026 she spoke with Law360 about a Massachusetts trade secret injunction ruling. Publications listed on her firm profile include “The DTSA Turns Ten: What a Decade of Litigation Tells Us” (May 2026) and “Trade Secrets: A Guide for Business” (January 2026). She is a Trustee of the Foundation for Advancement of Diversity in IP Law, a board member of The Alan D. Lourie Boston Intellectual Property American Inn of Court, and a Fellow of the American Bar Foundation.

  • Experience

Ms. Fiacco won summary judgment for Alexion Pharmaceuticals in the District of Massachusetts on Amyndas Pharmaceuticals’ trade secrets, unfair competition, and related claims, after which Amyndas dismissed its remaining contract claim with prejudice. She represented Krystal Biotech against trade secret misappropriation and unfair competition claims brought by PeriphaGen, obtaining a favorable settlement. As lead counsel for Bioverativ, she obtained claim construction rulings supporting infringement claims and a request for injunctive relief against CSL. She also served as trial counsel for Dana-Farber Cancer Institute in inventorship litigation against Bristol-Myers Squibb and Ono Pharmaceutical, a judgment the Federal Circuit affirmed.

 

Robert Haney, Jr., Partner | Foley Hoag LLP

Robert Haney, Jr. litigates non-competition, trade secret, and executive employment disputes in trials and arbitrations, and advises and conducts internal investigations on employment and trade secret issues. He leads the Labor & Employment practice in Foley Hoag LLP’s New York office and has more than 30 years of experience, with a focus on the biotech and technology industries.

  • Education & Credentials

Mr. Haney earned his J.D. from Harvard Law School in 1983, an M.P.P. from the John F. Kennedy School of Government in 1983, and a B.A., summa cum laude, from Middlebury College in 1978. He is admitted in New York and New Jersey and before the U.S. District Courts for the Southern and Eastern Districts of New York and the Second Circuit Court of Appeals. He speaks French.

  • Recognition & Leadership

Mr. Haney has been listed in Best Lawyers for Commercial Litigation (2017-2023) and in New York Super Lawyers (2014-2025).

  • Professional Involvement

His recent speaking engagements include WIPR Trade Secrets East (October 2026) and Trade Secrets Symposium 2026: Navigating the Law of Trade Secrets and Restrictive Covenants (February 2026). Publications listed on his firm profile include “Litigating Trade Secret Claims Focused on Generative AI” (May 2026) and “Two Circuit Courts Award Millions in Damages in Trade Secrets Cases, Utilizing Different Valuation Methods” (September 2022). He serves on the Labor and Employment Law Committee of the Association of the Bar of the City of New York, the ABA Committee on Employment Law, and the International Arbitration Committee of the International Bar Association.

  • Experience

In First Wave et al. v. Lycera (D. Del. 2018), Mr. Haney obtained summary judgment establishing his clients’ ownership of patents that the defendant alleged were based on trade secrets stolen by former employees who had joined First Wave. He represented Illumina, Inc. and several officers and former officers in obtaining dismissal of all claims in Zirvi, et al. v. Flatley, et al. (SDNY) on grounds including the statute of limitations and failure to adequately plead trade secrets. In Flatiron v. Carson (January 2020), he led the trial team that obtained an injunction enforcing a non-compete agreement against a senior data scientist for its full term, and for Creditex he obtained enforcement of employee non-competition agreements in two FINRA arbitrations. His firm profile notes that some of these matters were handled before he joined Foley Hoag.

 

Allison Anderson, Partner | Foley Hoag LLP

Allison Anderson litigates non-compete and theft of trade secret cases, among other high-stakes employment disputes, and has tried jury and bench cases in state and federal court and before administrative agencies. She co-chairs the Labor & Employment Practice at Foley Hoag LLP in Boston and represents companies in all aspects of labor and employment law.

  • Education & Credentials

Ms. Anderson earned her J.D., magna cum laude, from Boston College Law School in 2013 and her B.A., magna cum laude, from Macalester College in 2008. She is admitted in Massachusetts and before the Massachusetts state courts, the Federal District Court for the District of Massachusetts, and the U.S. Court of Appeals for the First Circuit.

  • Recognition & Leadership

Massachusetts Lawyers Weekly named Ms. Anderson to its Top Women of Law in 2023. The Best Lawyers in America has listed her for Employment Law – Management and Labor Law – Management (2024-2027), following Ones to Watch recognition (2021-2023). Boston Magazine named her a Top Lawyer in Labor and Employment (2025), and Law360 named her a 2026 Rising Star.

  • Professional Involvement

Firm programs listed on her profile include “Protecting Your Trade Secrets in 2023” (December 2022). She is a member of the American Bar Association’s Labor and Employment Section and serves the NLRB Practice and Procedure Committee as Program Co-Chair (2023-present) and Region One Co-Chair (2017-present). She is a chapter editor of How to Take a Case Before the NLRB.

  • Experience

Ms. Anderson defended an investment firm in Delaware Chancery Court litigation over its hiring of numerous top-level employees, defeating a preliminary injunction motion. She has negotiated numerous non-competition agreements on behalf of hiring employers and advised clients seeking to enforce such agreements. For a life sciences consulting firm, she won a multi-million dollar jury verdict and bench trial award on federal and state trade secret, unfair competition, and tortious interference claims in the federal district court in Massachusetts, then argued and prevailed on appeal before the First Circuit. She also obtained a preliminary injunction enforcing a non-competition agreement for a pharmacy business in the federal district court in Rhode Island and defeated an appeal of that order.

 

Urszula Nowak, Ph.D., Partner | Foley Hoag LLP

Urszula Nowak, Ph.D. focuses her practice on biotechnology and pharmaceutical patent and trade secret litigation and other biotechnology-related commercial disputes. She is a partner at Foley Hoag LLP in Boston and brings scientific training to her litigation work.

  • Education & Credentials

Dr. Nowak earned her J.D., Order of the Coif, from Fordham University School of Law in 2017, where she was a member of the Fordham Law Review. She holds a Ph.D. in Immunology from Cornell University (2011) and an M.S. in Immunology (2005) and a B.S. in Microbiology and Immunology (2003) from McGill University. She is admitted in New York and Massachusetts and before the U.S. Supreme Court, the U.S. District Court for the District of Massachusetts, and the U.S. Court of Appeals for the Federal Circuit. She speaks Polish.

  • Recognition & Leadership

Dr. Nowak has been listed in Best Lawyers: Ones to Watch for Litigation – Intellectual Property (2024-2026) and Litigation – Patent (2026), and was named a Managing IP Rising Star (2024). She received a Cancer Research Institute Predoctoral Fellowship.

  • Professional Involvement

Her recent speaking engagements include WIPR Trade Secrets East (October 2026). Publications listed on her firm profile include “The DTSA Turns Ten: What a Decade of Litigation Tells Us” (May 2026) and “Trade Secrets: A Guide for Business” (January 2026). She co-chaired the Patent Law Committee of the Boston Intellectual Property Law Association from 2020 to 2025 and has filed amicus briefs on behalf of the American Intellectual Property Law Association.

  • Experience

Dr. Nowak was part of the team that won summary judgment for Alexion Pharmaceuticals in the District of Massachusetts on Amyndas Pharmaceuticals’ trade secrets, unfair competition, and related claims. She represented Krystal Biotech in litigation brought by PeriphaGen alleging misappropriation of trade secrets and unfair competition, and represented Dana-Farber Cancer Institute in inventorship and ownership litigation against Bristol-Myers Squibb and Ono Pharmaceutical. Before practicing law, she worked as a scientific advisor for intellectual property litigation and was a Postdoctoral Fellow of Investigative Pharmacology at Hoffmann-La Roche Inc.

Agenda

SESSION 1 – Building the Defendant’s Record Against a Trade Secret Injunction: Stipulations and Damages Proof | Barbara A. Fiacco & Allison Anderson & Robert Haney, Jr. & Urszula Nowak | 12:00pm – 1:00pm

This session addresses defense-side strategy in the early stages of a trade secret injunction proceeding, including strategic concessions, stipulated orders, and developing the evidentiary record on harm and damages. The session covers early response strategy for TRO and preliminary injunction motions; challenging venue and choice of law; the role of non-competes and their interaction with trade secret issues; strategic concessions and stipulated orders; building the evidentiary record on harm and damages; and considerations for hiring companies including separate counsel for the employees.

BREAK | 1:00pm – 1:10pm

SESSION 2 – Briefing and Arguing the Defendant’s Opposition to a Trade Secret Preliminary Injunction | Barbara A. Fiacco & Allison Anderson & Robert Haney, Jr. & Urszula Nowak | 1:10pm – 2:10pm

This session addresses briefing and arguing the opposition to a trade secret preliminary injunction, with a focus on irreparable harm, approaches across jurisdictions, and narrowing the relief sought. The session covers lack of irreparable harm as a ground for opposition; presenting evidence on harm and damages across jurisdictions; effectively arguing public policy concerns; narrowing the scope of requested relief and requesting a bond; and hearing strategy and proposed orders.

Credits

Alaska

Approved for CLE Credits
2 General

Our programs are CLE-eligible through Alaska’s recognition of multi-jurisdictional reciprocity.
Alabama

Approved for CLE Credits
2 General

Arkansas

Approved for CLE Credits
2 General

Arizona

Approved for CLE Credits
2 General

California

Approved for CLE Credits
2 General

Colorado

Pending CLE Approval
2 General

Connecticut

Approved for CLE Credits
2 General

District of Columbia

No MCLE Required
2 CLE Hour(s)

Delaware

Pending CLE Approval
2 General

Florida

Approved via Attorney Submission
2 General Hours

Receive CLE credit in Florida via attorney submission.
Georgia

Pending CLE Approval
2 General

Hawaii

Approved for CLE Credits
2 General

Iowa

Pending CLE Approval
2 General

Idaho

Pending CLE Approval
2 General

Illinois

Pending CLE Approval
2 General

Indiana

Pending CLE Approval
2 General

Kansas

Pending CLE Approval
2 Substantive

Kentucky

Pending CLE Approval
2 General

Louisiana

Pending CLE Approval
2 General

Massachusetts

No MCLE Required
2 CLE Hour(s)

Maryland

No MCLE Required
2 CLE Hour(s)

Maine

Pending CLE Approval
2 General

Michigan

No MCLE Required
2 CLE Hour(s)

Minnesota

Pending CLE Approval
2 General

Missouri

Approved for CLE Credits
2.4 General

Mississippi

Pending CLE Approval
2 General

Montana

Pending CLE Approval
2 General

North Carolina

Pending CLE Approval
2 General

North Dakota

Approved for CLE Credits
2 General

Our programs are CLE-eligible through North Dakota’s recognition of multi-jurisdictional reciprocity. Section 1, Policy 1.14
Nebraska

Pending CLE Approval
2 General

myLawCLE reports attendance to Nebraska on each attorney’s behalf for all programs. Please do not self-report.
New Hampshire

Approved for CLE Credits
120 General minutes

As of July 1, 2014, the NHMCLE Board no longer provides pre- or post-approval of courses. Attendees must self-determine whether a program is eligible for credit, and self-report their attendance online at www.nhbar.org, based on qualification provisions of Rule 53.
New Jersey

Approved for CLE Credits
2 General

Our programs are CLE-eligible through New Jersey’s recognition of multi-jurisdictional reciprocity, except for the courses required under BCLE Reg. 201:2
New Mexico

Approved for CLE Credits
2 General

Nevada

Pending CLE Approval
2 General

New York

Approved for CLE Credits
2 General

Our programs are CLE-eligible through New York’s Approved Jurisdiction Group “B”.
Ohio

Approved for CLE Credits
2 General

Oklahoma

Pending CLE Approval
2.5 General

Oregon

Pending CLE Approval
2 General

Pennsylvania

Approved for CLE Credits
2 General

Rhode Island

Pending CLE Approval
2.5 General

South Carolina

Pending CLE Approval
2 General

South Dakota

No MCLE Required
2 CLE Hour(s)

Tennessee

Approved for CLE Credits
2 General

Texas

Approved for CLE Credits
2 General

Utah

Pending CLE Approval
2 General

Virginia

Not Eligible
2 General Hours

Vermont

Approved for CLE Credits
2 General

Washington

Approved via Attorney Submission
2 Law & Legal Hours

Receive CLE credit in Washington via attorney submission.
Wisconsin

Pending CLE Approval
2 General

West Virginia

Pending CLE Approval
2.4 General

Wyoming

Pending CLE Approval
2 General

More CLE Webinars
Upcoming CLE Webinars
Obtaining and Using Social Media Evidence (2026 Edition)
Obtaining and Using Social Media Evidence (2026 Edition) Tue, November 24, 2026
On-Demand
Live Replay
False Claims Act Hot Topics (2026 Edition)
False Claims Act Hot Topics (2026 Edition) Tue, December 1, 2026
Live Webcast
HIPAA Privacy, Security and AI – Oh My!
HIPAA Privacy, Security and AI – Oh My! Tue, December 1, 2026
Live Webcast
Mini-Med School Orthopedic Trauma Edition
Mini-Med School Orthopedic Trauma Edition Thu, December 3, 2026
Live Webcast